WS
NURO

Wedbush Securities’s NeuroMetrix, Inc. Common Stock NURO Stock Holding History

Wedbush Securities’s Portfolio NURO Stock Details NURO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-4,355
Closed -$59K – 1002
2020
Q3 		$59K Buy
4,355
+1,780
+69% +$26.9K 0.01% 869
2020
Q2 		$42K Buy
+2,575
New +$44.4K ﹤0.01% 921

Other funds holding NURO

VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wedbush Securities's NURO Position: Q4 2020 in Review

Wedbush Securities sold out of NeuroMetrix, Inc. Common Stock (NURO) in Q4 2020, closing a stake of 4,355 shares — an estimated $59K sold.

Wedbush Securities first reported a position in NURO in Q2 2020 and held it in 2 quarters. The position peaked at $59K in Q3 2020. 9 funds tracked by Wall St. Rank hold NURO as of Q4 2020.

  • Wedbush Securities reported no remaining NeuroMetrix, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Wedbush Securities sold 4,355 NeuroMetrix, Inc. Common Stock shares in Q4 2020, an estimated $59K.
  • Wedbush Securities first reported a position in NeuroMetrix, Inc. Common Stock in Q2 2020 and held it in 2 quarters.
  • Wedbush Securities's NeuroMetrix, Inc. Common Stock position peaked at $59K in Q3 2020.
  • 9 funds tracked by Wall St. Rank held NeuroMetrix, Inc. Common Stock as of Q4 2020.

Based on Wedbush Securities's 13F filing for Q4 2020, filed 16 Feb 2021.